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Abstract 
Three hundreds and thirty eight nasopharyngeal aspirates from children with Adenovirus 
respiratory tract infection admitted to the caritas baby hospital between January 2005 and Dec 
2010 were studied in this work.  All children were residing southern Palestine; districts Hebron 
and Bethlehem.  The epidemiological characteristics of Adenovirus were investigated by 
significant test results (one sample test for association and Pearson test for correlation) in detail 
by examination of 95% confidence intervals for each category.  In terms of residency, most 
children with adenoviral infections were from villages (68%), in terms of age distribution, most 
cases were among infants (62%), in terms of sex distribution, most cases were among males 
(62%).  Regarding seasonal occurrence, the largest number of Adenoviral infections occurred 
during winter and spring months.  Most infants and children diagnosed with Adenovirus 
respiratory tract infection suffered mainly from Bronchitis, Bronchopneumonia (33.3%) and 
upper respiratory tract infections (URTI, 24.7%).  The major symptom found in 80% of children 
was fever, followed by cough, found in 50% of the children.   Despite etiology of the viral 
infection, 70% of children had been treated with antibiotic. Utilizing genetic analysis of the 
samples, different sizes of hexon genes were detected via polymerase chain reaction (PCR).  
Sequence analysis of the samples' DNA revealed that different Adenovirus serotypes were 
circulating in southern Palestine, mainly; HADV-1,   HADV-2, HADV-3 and HADV-5.  The 
most frequent serotypes however, were HADV-1, HADV-2 and HADV-3.  Precise alignment 
and Phylogenetic analysis generated by neighbor-joining method of Palestinian sample's amino 
acids were in agreement with the DNA analysis.  Surprisingly, some Palestinian serotypes were 
found to be homolog for two different reference HADV serotypes simultaneously, suggesting 
that they may be representing new unpublished serotypes.  Interestingly, the different serotypes 
found in southern Palestine did not correlate specifically to residency, age or sex of the diseased 
children.  The most striking finding was that some serotypes correlated strongly to specific 
seasons, rather than others.  While serotypes HADV-2 and HADV-3 occurred mainly in the 
spring months, HADV-1 and HADV-5 were found predominantly in the winter months. 
In conclusion, applying molecular Biology based methodology for detection of infectious 
diseases in combination with epidemiological data is becoming an urgent and essential approach 
in developing strategies for control and treatment of viral infections.  
 V
 
 
  اﻟﻤﻠﺨﺺ 
ﺑﻔﻴﺮوس اﻻدﻳﻨﻮ هﻮ اﻟﻰ ﻣﺸﻔﻰ اﻟﻜﺮﻳﺘﺎس  اﻋﺪد اﻟﻌﻴﻨﺎت اﻟﻤﺎﺧﻮذة ﻣﻦ اﻟﻤﺠﺎري اﻟﺘﻨﻔﺴﻴﺔ آﺎﻟﺤﻠﻖ واﻻﻧﻒ ﻟﻼﻃﻔﺎل اﻟﺬﻳﻦ دﺧﻠﻮآﺎن 
آﺎﻧﻮن ﺟﺮت اﻟﺪراﺳﺔ ﻓﻲ اﻟﻔﺘﺮة اﻟﻤﻤﺘﺪة ﺑﻴﻦ . وهﻮ ﻓﻴﺮوس ﻳﺼﻴﺐ ﺑﺸﻜﻞ ﻋﺎم اﻟﻘﻨﺎة اﻟﺘﻨﻔﺴﻴﺔ ﺧﺎﺻﺔ ﺑﻴﻦ اﻻﻃﻔﺎل ،833
 .وآﺎن ﺟﻤﻴﻊ اﻻﻃﻔﺎل اﻟﺬﻳﻦ ﺗﻢ ﺷﻤﻠﻬﻢ ﻓﻲ اﻟﺪراﺳﺔ ﻣﻦ ﻣﻨﻄﻘﺔ ﺟﻨﻮب ﻓﻠﺴﻄﻴﻦ اي اﻟﺨﻠﻴﻞ وﺑﻴﺖ ﻟﺤﻢ ,آﺎﻧﻮن ﺛﺎﻧﻲ 0102-5002اول
ﻟﻜﻞ ﻋﺎﻣﻞ % 59  ICﻻدﻳﻨﻮ ﺗﻢ ﻓﺤﺼﻬﺎ ﻋﻦ ﻃﺮﻳﻖ ﺑﺮﻧﺎﻣﺞ اﻟﺘﺤﻠﻴﻞ اﻻﺣﺼﺎﺋﻲ ﺑﻮاﺳﻄﺔ ﻣﻘﻴﺎس اﻟﺜﻘﺔاﻟﺨﺼﺎﺋﺺ اﻟﻮﺑﺎﺋﻴﺔ ﻟﻔﻴﺮوس ا
ﺑﺎﻟﻨﺴﺒﺔ ﻟﻤﻜﺎن   .  )noitalerroc rof tset nosraeP dna noitaicossa rof tset elpmas eno(ﻣﻦ ﻋﻮاﻣﻞ اﻟﻤﺮض
اﻣﺎ ﻣﻦ ﻧﺎﺣﻴﺔ اﻟﺘﻮزﻳﻊ %. 86ﻮن اﻟﻘﺮى ﺑﻨﺴﺒﺔ دﻳﻨﻮ هﻮ ﺑﻴﻦ اﻻﻃﻔﺎل اﻟﺬﻳﻦ ﻳﺴﻜﻨاﻻﻗﺎﻣﺔ آﺎﻧﺖ اآﺜﺮ اﻟﺤﺎﻻت اﻧﺘﺸﺎرا ﺑﻔﻴﺮوس اﻻ
اﻣﺎ ﺑﺎﻟﻨﺴﺒﺔ ﻟﻠﺘﻮزﻳﻊ ﺣﺴﺐ %. 26اﻟﻌﻤﺮي ﻟﻼﻃﻔﺎل اﻟﻤﺼﺎﺑﻴﻦ ﺑﺎﻟﻔﻴﺮوس آﺎﻧﺖ اآﺜﺮ اﻟﺤﺎﻻت ﺑﻴﻦ اﻻﻃﻔﺎل دون ﻋﻤﺮ اﻟﺴﻨﺔ وهﻲ 
ﻣﻦ ﺣﻴﺚ ﺣﺪوث اﻟﻤﺮض %. 26اﻋﻠﻰ ﻣﻦ اﻻﻧﺎث ﺣﻴﺚ آﺎﻧﺖ اﻟﻨﺴﺒﺔ ﺑﻴﻦ اﻟﺬآﻮر ﺗﺴﺎوي  اﻟﻤﺼﺎﺑﻴﻦاﻟﺠﻨﺲ آﺎﻧﺖ ﻧﺴﺒﺔ اﻟﺬآﻮر
ﻣﻦ اﻻﻣﻮر اﻟﻬﺎﻣﺔ اﻟﺘﻲ ﻟﻮﺣﻈﺖ ﻋﻠﻰ . ﻨﺴﺒﻪ ﻟﻼﺷﻬﺮ ﻓﻜﺎن اﻋﻠﻰ ﺣﺪوث ﻟﻼﺻﺎﺑﺔ ﺑﺎﻟﻔﻴﺮوس ﻓﻲ ﻓﺼﻞ اﻟﺸﺘﺎء واﺷﻬﺮ اﻟﺮﺑﻴﻊﺑﺎﻟ
ﺣﺪﻳﺜﻲ اﻟﻮﻻدة واﻻﻃﻔﺎل اﻟﻤﺼﺎﺑﻴﻦ ﺑﺎﻟﻔﻴﺮوس اﻧﻬﻢ آﺎﻧﻮا ﻳﻌﺎﻧﻮن ﺑﺸﻜﻞ رﺋﻴﺴﻲ ﻣﻦ اﻟﺘﻬﺎﺑﺎت رﺋﻮﻳﺔ واﻟﺘﻬﺎﺑﺎت ﻓﻲ اﻟﺸﻌﺐ اﻟﻬﻮاﺋﻴﺔ 
اﻣﺎ ﻋﻦ اهﻢ اﻻﻋﺮاض %. 7.42ري اﻟﺘﻨﻔﺴﻴﺔ اﻟﻌﻠﻴﺎ ﺑﻨﺴﺒﺔ ﺗﺴﺎوي  ﺎﻟﺘﻬﺎﺑﺎت ﻓﻲ اﻟﻤﺠﻳﻌﺎﻧﻮن ﻣﻦ ا اوآﺎﻧﻮ% 3.33ﺑﻨﺴﺒﺔ ﺗﺴﺎوي 
 اﻣﺎ ﻋﻠﻰ ﺻﻌﻴﺪ اﻟﻌﻼج ﻓﻘﺪ ﺗﻢ اﻋﻄﺎء %. 05واﻟﺴﻌﺎل ﺑﻨﺴﺒﺔ ﺗﺴﺎوي % 08اﻟﻤﺼﺎﺣﺒﺔ ﻟﻔﻴﺮوس اﻻدﻳﻨﻮ ﻓﻜﺎﻧﺖ اﻟﺤﻤﻰ ﺑﻨﺴﺒﺔ ﺗﺴﺎوي 
  . ﺔﺣﻴﻮﻳ اتﻓﻴﺮوس اﻻدﻳﻨﻮ ﻣﻀﺎدوآﺎن ﻟﺪﻳﻬﻢ  ﻣﻦ اﻻﻃﻔﺎل اﻟﺬﻳﻦ دﺧﻠﻮ اﻟﻰ اﻟﻤﺸﻔﻰ% 07
 اﻟـ ﺗﻢ ﺗﺤﺪﻳﺪ هﺬﻩ اﻟﺘﻨﻮﻋﺎت ﻋﻦ ﻃﺮﻳﻖ .اﻟﺬي ﻳﺤﺘﻮي ﻋﻠﻰ آﻞ اﻻﺧﺘﻼﻓﺎت ﻟﻠﺴﻼﻻت اﻟﺠﻴﻨﻴﺔ ﻟﻠﻔﻴﺮوس noxeHﺗﻢ ﺗﺤﻠﻴﻞ ﺟﻴﻦ 
ﺟﻮدة ﻓﻲ ﻟﻔﻴﺮوس اﻻدﻳﻨﻮ اﻟﻤﻮاﻟﺠﻴﻨﻴﺔ  اﻟﺴﻼﻻتﺗﺤﻠﻴﻞ . ﻟﻜﻞ ﻋﻴﻨﺔ ﻟﻤﻌﺮﻓﺔ اﻟﺴﻼﻻت اﻟﻤﺨﺘﻠﻔﺔ ﻟﻠﻔﻴﺮوس وﺣﺠﻤﻬﺎ ANDﻟِـ  RCP
 وﻟﻜﻦ اآﺜﺮ اﻟﺴﻼﻻت اﻧﺘﺸﺎرا آﺎﻧﺖ -1-VDAH, 3-VDAH,2-VDAH ,5-VDAH ﺟﻨﻮب ﻓﻠﺴﻄﻴﻦ دﻟﺖ ﻋﻠﻰ وﺟﻮد
-robhgien ﻘﺔ واﻟﺸﺠﺮة اﻟﺠﻴﻨﻴﺔ اﻟﺘﺤﻠﻴﻠﻴﺔ ﺑﻨﻴﺖ ﻋﻠﻰ اﺳﺎس ﻃﺮﻳﻘﺔ ﺗﺴﻤﻰاﻟﻤﻄﺎَﺑ ,1-VDAH.   2-VDAH, 3-VDAH
ﻣﻦ اﻟﻤﺪهﺶ ان ﺑﻌﺾ اﻟﺴﻼﻻت ﻓﻲ ﻓﻠﺴﻄﻴﻦ وﺟﺪت . ﻟﻤﻨﻄﻘﺔ ﺟﻨﻮب ﻓﻠﺴﻄﻴﻦ اﻻﻣﻴﻨﻲ ﻟﻠﺤﻤﺾ اﻟﻨﻮوي واﻟﺤﻤﺾ  gninioj
ﻣﻦ ﻓﻴﺮوس اﻻدﻳﻨﻮ اﻟﻤﻜﺘﺸﻔﺔ ﺳﺎﺑﻘﺎ وهﺬا اﻻﻣﺮ ﻳﻤﻜﻦ ان ﻳﻘﻮد اﻟﻰ اﻳﺠﺎد ﺳﻼﻻت ﺟﺪﻳﺪة ﻏﻴﺮ ﻓﻲ ﻧﻔﺲ اﻟﻮﻗﺖ ﻄﺎﺑﻘﺔ ﻟﺴﻼﻟﺘﻴﻦ ﻣ
اﻟﺴﻼﻻت اﻟﻤﺨﺘﻠﻔﺔ اﻟﺘﻲ وﺟﺪﻧﺎهﺎ ﻓﻲ ﺟﻨﻮب ﻓﻠﺴﻄﻴﻦ ﻻ ﺗﺮﺗﺒﻂ ﺑﺎﻟﺘﻮزﻳﻊ اﻟﺠﻐﺮاﻓﻲ واﻟﻌﻤﺮ . ﻓﺔ ﻣﻦ ﻗﺒﻞّﺮﻣﻮﺟﻮدة او ﻏﻴﺮ ﻣﻌ
 اﻻﺻﺎﺑﺎت ﺑِـ ﺑﻴﻨﻤﺎ ،ﻼﻻت ﺗﺮﺗﺒﻂ ﺑﺸﻜﻞ ﻗﻮي ﻣﻊ اﺷﻬﺮ ﻣﻌﻴﻨﺔ اآﺜﺮ ﻣﻦ ﻏﻴﺮهﺎواﻟﺠﻨﺲ ﻟﻼﻃﻔﺎل اﻟﻤﺼﺎﺑﻴﻦ وﻟﻜﻦ ﺑﻌﺾ اﻟﺴ
ﻓﻜﺎن ﻓﻲ اﺷﻬﺮ     1-VDAH و  5-VDAH اﻻﺻﺎﺑﺎت ﺑِـ اﻣﺎ ﺑﺸﻜﻞ رﺋﻴﺴﻲ ﻓﻲ اﺷﻬﺮ اﻟﺮﺑﻴﻊ ﺣﺪﺛﺖ 3-VDAH,2-VDAH
    .اﻟﺸﺘﺎء
ﻟﺘﻄﻮﻳﺮ  ﺎوﺿﺮورﻳ ﺎاﺻﺒﺢ هﺎﻣوﺗﺤﺪﻳﺪ اﻻﻣﺮاض اﻟﻤﻌﺪﻳﺔ  ﻓﻲ ﺑﺌﺔ واﻻﺣﻴﺎء اﻟﺠﺰﻳﺌﻴﺔ هﻮ اﺳﺎسﺗﻄﺒﻴﻖ ﻋﻠﻢ اﻻو: اﻟﺨﻼﺻﺔ 
    .  اﺳﺘﺮاﺗﻴﺠﻴﺎت ﻟﻠﺴﻴﻄﺮة ﻋﻠﻰ اﻧﺘﺸﺎر اﻟﻤﺮض واﻳﺠﺎد اﻟﻌﻼج ﻟﻼﺻﺎﺑﺎت واﻻﻟﺘﻬﺎﺑﺎت اﻟﻔﻴﺮوﺳﻴﺔ
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1 
 
1. Introduction 
 
1.1 Respiratory tract infections and common cold 
Respiratory tract infections are a major cause of human morbidity, and are caused by a broad 
spectrum of microbial agents.  Upper respiratory tract infections are a leading cause of time lost 
from work and school, consuming large amounts of health care financial resources (Allander et 
al., 2005).  Viruses account for the largest number of respiratory tract infections.Bacteria account 
for up to 25 percent of upper respiratory tract infections (Goldmann et al., 2003). The so-called 
respiratory viruses include influenza virus A and B, parainfluenza viruses, Adenoviruses, 
respiratory syncytial virus (RSV), rhinoviruses, and corona viruses.  In recent years, several 
novel viruses have been discovered in patients with respiratory infections using molecular 
biology methods (Weissbrich et al., 2006).  These novel viruses include the human 
metapneumovirus and several corona viruses (SARS, NL63, and HKU1) (Fouchier et al., 2005). 
The latest addition to this list was the human Boca virus (hBoV) described by Allander et al. 
(Allander et al., 2005). 
 
Rhinoviruses and corona viruses together cause more than 50 % of “colds.”  The common cold 
(viral upper respiratory tract infection; VURTI, acute viral Rhinopharyngitis, acute coryza, or 
cold) is a contagious, viral infectious disease of the upper respiratory system, caused primarily 
by rhinoviruses and corona viruses (Arden and Mackay, 2010).  Typical symptoms include 
cough, sore throat, rhino rhea (runny nose), and fever.   The common cold is the most frequent 
infectious disease in humans with an average of two to four infections a year in individual adults 
and up to 6–12 infections per year in children.  Collectively, colds, influenza, and other 
infections with similar symptoms are included in the diagnosis of influenza-like illness and are 
also termed “upper respiratory tract infections” (URTI).  Influenza involves infection of the 
lungs while the common cold does not (Olenec et al., 2010).  Common colds are droplet-borne 
infections, which means that they are primarily transmitted through breathing in tiny particles 
that the infected person emits when he or she coughs, sneezes, or exhales. 
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1.1.1 Influenza 
Influenza viruses are classic respiratory viruses and cause endemic, epidemic and pandemic 
influenza.  There are three types of influenza virus: A, B, and C. Influenza A viruses causes 
epidemics and occasionally pandemics, and there is an animal reservoir, notably in birds.  
Influenza B viruses only cause epidemics and do not involve animal hosts.  Influenza C viruses 
do not cause epidemics and give rise to only minor respiratory illness (Mims, 2004). 
 
 
1.1.2 Parainfluenza virus (HPIV) 
HPIVs primarily affect young children and the pathogenic spectrum includes upper and lower 
respiratory tract infections.  HPIVs are responsible for 30%-40% of all acute respiratory tract 
infections in infants and children.  These conditions include common colds with fever, croup, 
bronchiolitis, and pneumonia.  HPIVs also cause community-acquired respiratory tract infections 
of variable severity in infants (Teo et al., 2010). 
 
 
1.1.3 Human respiratory syncytial virus (RSV) 
(RSV) is a virus that causes respiratory tract infections.  It is the major cause of lower respiratory 
tract infection and hospital visits during infancy and childhood. 75 % of bronchiolitis infections 
are caused by respiratory syncytial virus (Mims, 2004).  There is no vaccine. Treatment is 
limited to supportive care, including oxygen.  In temperate climates there is an annual epidemic 
during the winter months.  In tropical climates, infection is most common during the rainy 
season (Hall et al., 2009). 
 
1.1.4 Metapneumovirus (HMPV) 
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HMPV is a respiratory pathogen closely related to RSV and is thought to occur mostly in the 
winter months.  It is associated with a spectrum of illness from mild infection to bronchiolitis 
and pneumonia (Mims, 2004).  
 
 
1.1.5 Coxackie and Bocaviruses 
The most well known Coxsackie A disease is hand, foot , and mouth disease (unrelated to foot 
and mouth disease), a common childhood illness which affects mostly children aged 10 or under, 
often produced by Coxsackie A16 (Rabenau et al., 2010).  In most cases, infection is 
asymptomatic or causes only mild symptoms. In others, infection produces short-lived (7–10 
days) fever and painful blisters in the mouth (a condition known as herpangia), on the palms and 
fingers of the hand, or on the soles of the feet. There can also be blisters in the throat, or on or 
above the tonsils, and other components of Waldeyer’s Ring.  Adults can also be affected. The 
rash, which can appear several days after high temperature and painful sore throat, can be itchy 
and painful, especially on the hands/fingers and bottom of the feet (Rabenau et al., 2010). 
Human Boca virus (HBoV) is a parvovirus, which causes lower respiratory tract infections.  
HBoV is found rarely in respiratory samples from healthy subjects.  In patients with respiratory 
complaints, it can be found alone or, more often, in combination with other viruses known to 
cause respiratory complaints (Ricour and Goubau, 2008).  Newborns are probably protected by 
passive immunization. Although the age group most frequently affected appears to be children 
between the ages of six months to two years (Endo et al., 2007), infection in children older than 
five and even in a 28-year-old have been reported (Kupfer et al., 2006). 
 
 
 
 
 
1.1.6 Adenoviruses   
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1.1.6.1 History 
Adenoviruses were first isolated and characterized as distinct viral agents by two groups who 
were searching for the etiologic agents of acute respiratory infections.  In 1953, Rowe and 
colleagues observed the spontaneous degeneration of primary cell cultures derived from human 
adenoids (Knipe et al., 2001).  The pathogenic changes proved to result from the replication of 
previously unidentified viruses present in the adenoid tissues. In 1954, Hilleman and Werner 
were studying an epidemic of respiratory disease in army recruits, and they isolated agents from 
respiratory secretions that induced cytopathic changes in cultures of human cells (McDonald et 
al., 1999).  
 
 In 1956, the agents were named Adenoviruses, after the original tissue (adenoid) in which the 
prototype viral strain was discovered (Knipe et al., 2001).  Epidemiologic studies confirmed that 
adenoviruses are the cause of acute febrile respiratory disease among military recruits (Ginsberg 
et al., 1955). It soon became clear, however, that Adenoviruses are not the etiologic agents of the 
common cold; they are responsible for only a small portion of acute respiratory morbidity in the 
general population and for about 5% to 10% of respiratory illness in children. Besides respiratory 
disease, Adenoviruses cause epidemic conjunctivitis (Niemann et al., 1993), and they have been 
associated with a variety of additional clinical syndromes—perhaps most notably, infantile 
gastroenteritis (Parrott et al., 1954). Today, more than 100 members of the adenovirus group 
have been identified that infect a wide range of mammalian and avian hosts. All of these viruses 
contain a linear, double-stranded DNA genome encapsulated in an icosahedral protein shell 
(Polvino-Bodnar et al., 1987).  In 1962, Trentin and colleagues made a seminal discovery: 
human adenovirus type 12 induces malignant tumors after inoculation into newborn hamsters.  
This was the first time that a human virus was shown to sponsor oncogenesis.  No epidemiologic 
evidence has been reported linking Adenoviruses with malignant disease in humans; extensive 
searches have generally failed to find Adenovirus nucleic acids in human tumors (Turner et al.; 
1993; Harmonet al., 1979). Nevertheless, the ability to induce tumors in animals and to transform 
cultured cells has established Adenovirus as an important model system for probing the 
mysteries of oncogenesis (Knipe et al., 2001). As the interest in adenoviruses as tumor viruses 
intensified, their virtues as an experimental system became evident (Knipe et al., 2001).  The 
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prototype human adenoviruses are easily propagated to produce high-titer stocks, and they 
initiate synchronous infections of established cell lines (Harmon et al., 1979). Furthermore, the 
viral genome is readily manipulated, facilitating the study of adenovirus gene functions by 
mutational analysis (Harmon et al, 1979). Studies of adenovirus-infected cells have made 
numerous contributions to the understanding of viral and cellular gene expression and regulation, 
DNA replication, cell cycle control, and cellular growth regulation (Knipe et al., 2001). 
 
 
 
1.1.6.2 Structure 
Adenoviruses represent the largest nonenveloped viruses. Because of their large size, they are 
able to be transported through the endosome (i.e. envelope fusion is not necessary).  The virion 
also has a unique "spike" or fiber associated with each penton base of the capsid that aids in 
attachment to the host cell via the coxsackie-adenovirus receptor on the surface of the host cells 
(Knipe et al., 2001; figure 1.1).  
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The Adenoviruses constitute the adenoviridae family of viruses, which is divided into two 
genera, Mastadenovirus and Aviadenovirus whereas the Aviadenovirus genus is limited to 
viruses of bird, the Mastadenovirus genus includes human, simian, murine, bovine, equine, 
porcine, ovine, canine, and opossum viruses.  Although there is antigenic cross – reactivity 
among members within each genus owing to conserved epitopes located on the hexon protein of 
the virion, there is no known antigen common to all Adenoviruses (Knipe et al., 2001). 
 
 
 
1.1.6.5 Serotypes 
Human Adenoviruses (HADVs) include 53 recognized serotypes assigned to seven species (A-
G) on the basis of biophysical, biochemical, and genetic criteria (Kajon et al., 2010).  Serotype 
correlates with the severity and symptomology of disease, as well as with epidemiological 
characteristics (Metzgar et al., 2007). Knowledge of circulating serotypes can also predict the 
potential usefulness of available vaccines. The worst epidemics, often caused by newly emerging 
genome types may occur in areas where the causal Serotype was rare in recent times (Noda et al., 
2002).  Species B includes two genetic clusters, subspecies B1 and B2. Between 2010 and today, 
further 5 adenoviral serotypes were identified making the total serotypes 58 respectively (Ishiko 
and Aoki, 2009; Walsh et al., 2010; Robinson et al., 2011) 
 
The serotypes of subspecies B1 (HADV-3, HADV-7, HADV-16, HADV-21, and HADVs- 50) 
generally cause acute respiratory disease (ARD) (Kajon et al 2010).  HADV-C species includes 
serotypes 1, 2, 5 and 6.  These serotypes are commonly associated with febrile respiratory illness 
in children and are noted to be endemic in certain regions (Metzgar et al., 2007).  Species E 
(HADV4) are also frequent causative agents of epidemic conjunctivitis and respiratory disease 
(Metzgar et al., 2007).  Recent respiratory outbreaks of a virulent strain of human Adenovirus 
B14 (HAdV-B14) led to the deaths of nine people in the United States during the 2006-2007 
respiratory season (Yeung et al., 2009). 
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1.1.6.6Life cycle 
The replication cycle is divided by convention into two phases that are separated by the onset of 
viral DNA replication (figure 1.3).  The replication cycle include adsorption, penetration, 
movement of the viral DNA to the nucleus, and expression of an early set of genes (Knipe et al., 
2001).  Early viral gene products mediate further viral gene expression and DNA replication, 
induce cell cycle progression, block apoptosis, and antagonize a variety of host antiviral 
measures (Knipe et al., 2001).  In HeLa cells infected at a multiplicity of 10 plaque-forming units 
per cell, the early phase lasts for 5 to 6 hours, after which viral DNA replication is first detected 
concomitant with the onset of viral DNA replication; the late phase of the cycle begins with 
expression of late viral genes and assembly of progeny virion.  The infectious cycle is completed 
after 20 to 24 hours in HeLa cells.  At the end of the cycle, about 104 progeny virus particles per 
cell have been produced, along with the synthesis of a substantial excess of virion proteins and 
DNA that are not assembled into virions.  Cells infected at high multiplicity seldom divide; 
hence, at the completion of the replication cycle, the DNA and protein content of the infected 
cell has increased by a factor of about two (Knipe et al., 2001). 
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Figure 1.3: Schematic representation of Adenovirus life cycle (Microbiology 
2009.wikispaces.com\Adenovirus+US). 
 
 
 
Although early and late are convenient terms for description of events that occur during the 
replication cycle, the functional distinction between early and late events is often blurred.  Early 
genes continue to be expressed at late times after infection, and the promoter controlling 
expression of the major late transcription unit directs a low level of transcription early after 
11 
 
infection.  The viral genes encoding proteins IVa2 and IX begin to be expressed at an 
intermediate time and thus form a delayed-early category (Knipe et al., 2001). 
 
 
1.1.6.7Clinical features 
 
1.1.6.7.1 Acute Respiratory Disease  
 
In many respects, ARD is similar to the description furnished earlier of the respiratory infection 
of children.  The syndrome is caused by HADV4, HADV7, and occasionally HADV3.   ARD is 
a syndrome that frequently occurs under the special conditions of fatigue and crowding created 
soon after the induction of young military recruits (Heubner et al., 1955).  It is less common 
among healthy adults. Some cases have had a fatal outcome from the pneumonitis that may 
accompany and complicate the other, milder respiratory symptoms (Knipe et al., 2001). 
 
 
 
1.1.6.7.2 Pertussis-like Syndrome 
The association of Adenovirus infection with a pertussis-like syndrome has been noted, leading 
to some speculation that adenoviruses rather than Bordetella pertussis caused many of the cases 
of clinical whooping cough (Knipe et al., 2001).  Claims were made that even the lymphocytosis 
of pertussis might be related to the Adenovirus infection (Collier et al., 1966). This point of view 
was given some credence by the isolation of an HADV5 from multiple organs of a patient with 
severe whooping cough with lymphocytosis that ended fatally (Collier et al., 1966).  Later data 
from a controlled study of 134 children with a pertussis-like illness and 101 healthy controls 
report the common association of Adenoviruses with whooping cough symptoms; however, there 
is no evidence that the adenoviruses alone are responsible for the syndrome.  The large number 
of Adenovirus isolates may be due to conditions favorable for reactivation of latent viruses from 
tonsillar tissue during concurrent B.pertussisinfection(Knipe et al., 2001). 
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1.1.6.7.3 Infections of the Eye 
An acute follicular conjunctivitis may occur as part of a respiratory-pharyngeal syndrome or as a 
separate entity (Bennett et al., 1957).  Both bulbar and palpebral conjunctival involvement may 
occur and affect both eyes.  The disease is often accompanied by significant preauricular 
lymphadenopathy (Bell et al., 1955).  Complete recovery without sequelae is the most common 
result of this rather mild illness. The incubation period is usually 6 to 9 days, but it was as short 
as 2 days in experimental infections in volunteers (Knipe et al., 2001).  Epidemiologically, these 
infections can occur sporadically or cause disease in large groups of contacts.  Family members 
may be affected.  When the source is a swimming pool or small lake, large numbers of children 
and young adults may develop symptoms. Swimming pool conjunctivitis is probably most 
commonly due to Adenoviruses (Knipe et al., 2001). Although the virus is isolated from the 
conjunctiva of affected individuals, it has not been isolated from water samples from putatively 
infected sources.  The common-source water-borne outbreaks usually occur in summer and are 
caused by HADV3 and HADV7.  However, other types, such as HADV1, HADV2, HADV4, 
HADV6, HADV9, HADV10, HADV11, HADV15, HADV16, HADV17, HADV20, and 
HADV22 (groups B, C, D, and E and HA groups I, II, and III) have been associated with this 
syndrome (Knipe et al., 2001). 
 
 
1.1.6.7.4 Acute Hemorrhagic Cystitis 
 
Acute hemorrhagic cystitis, an illness occurring almost exclusively in boys and associated with 
HADV11, HADV7, HADV35 and HADV21 is characterized by gross hematuria. Its significance 
lies in the potential confusion with other, more serious diseases of the kidney (such as 
glomerulonephritis). This self-limited disease is usually not accompanied by fever or 
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hypertension, and tests of renal excretory and concentrating functions have been essentially 
normal (Akiyama et al., 2001). 
 
 
 
1.1.6.7.5 Meningoencephalitis 
 
It is rare to isolate any of the Adenoviruses from either the cerebrospinal fluid (CSF) or the brain. 
However, several reports have directly detected adenoviruses in CSF (HADV3, HADV5, 
HADV6, HADV7, HADV7A, and HADV12) (Knipe et al., 2001). One patient with malignant 
lymphoma, immunosuppressed by chemotherapy, had an HADV32 isolated from brain at 
autopsy (Chou et al., 1973). There are other cases of meningoencephalitis in which viral isolation 
from extra neural sites or antibody titer increases have been used to make a diagnosis, especially 
associated with epidemic HADV7 pneumonia in children (Knipe et al., 2001).  A case of sudden 
unilateral deafness was associated with an HADV3 infection of the nasopharynx (Knipe et al., 
2001). 
 
 
 
1.1.6.7.6 Gastrointestinal Diseases 
The relationship between Adenoviruses and diarrhea has had a long and complicated history, but 
has been clarified considerably in recent years (Knipe et al., 2001).Because many Adenoviruses 
replicate efficiently in the intestine and are excreted in the stool, it was assumed that they would 
be strong candidates for causing diarrhea (Knipe et al., 2001).  However, earlier epidemiologic 
studies generally found as many Adenovirus isolates in the stools of controls as in those with 
diarrhea (Ramos-Alvarez and Sabin, 1958). The failure to correlate Adenovirus growth from 
stool with clinical illness was a good example that Adenoviruses should not be designated as the 
cause of a whole spectrum of medical illnesses just because they can be cultured from the stool 
of an individual with a disease. Normal children can clearly shed Adenoviruses in stool and often 
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develop antibodies to the particular type grown (Hillis et al., 1973). These sub-clinical infections 
probably result in lifelong immunity. That young children with systemic adenovirus infections 
can develop diarrhea as an accompanying problem is well known but probably no more common 
than after any other systemic infection (Knipe et al., 2001). 
 
 
 
1.1.6.8 Diagnosis 
 
Antigen detection, polymerase chain reaction (PCR) assay, virus isolation, and serology can be 
used to identify adenovirus infections.  Adenovirus typing is usually accomplished by 
hemagglutination-inhibition and/or neutralization with type-specific antisera.  Since Adenovirus 
can be excreted for prolonged periods, the presence of virus does not necessarily mean it is 
associated with disease (Chmielewicz et al., 2005 b). 
 
 
 
 
1.1.6.8.1 Serum neutralization  
Type specific identification is classically performed by serum neutralization (SN) and /or 
hemagglutination inhibition (HI) assays, the type–specific determinants of HADVs recognized 
by SN are located primarily on the surface of the hexoncapsomere,but determinants are also 
present on the fiber and, to a  lesser extent,on the penton proteins (Lu and Erdman, 2006). 
 
 
 
1.1.6.8.2 Immunotyping 
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Immunotyping HADVs by classical methods is labor intensive, dependent on hyper immune 
polyclonal reagents that are in short supply, and results can be delayed for weeks. Moreover, 
interpreting assay results can be difficult, given extensive cross reactions between some Ad 
serotypes, particularly among species A and D viruses (Wigand, 1987). Type-specific 
monoclonal antibodies have been developed for a limited number of HADV, but these reagents 
are not widely available (Wood et al., 1997). 
 
 
 
 
1.1.6.8.2 Direct Immunofluorescence (DFA) 
Hereby, an Adenoviral antigen is detected using an antigen-specific antibody against it tagged 
with a fluorescent dye.  This method is generally the first line of respiratory tract infections in 
nasopharyngeal aspirates, since it offers a straight-forward detection of viral antigen (D`Alessio 
et al., 1970). 
 
 
1.1.6.8.3 Restriction fragment length polymorphism analysis  
In the early 1980s, molecular typing of HADVs by genomic restriction fragment length 
polymorphism (RFLP) analysis was proposed as an alternative to immunotyping (Adrian et al., 
1986).  Genomic RFLP analysis offered a comprehensive assessment of genetic variation across 
the entire viral genome and remains a popular tool for strain characterization of some HADV 
serotypes.  However, this method requires cultured virus, is labor intensive, and results for some 
serotypes can be difficult to interpret due to novel RFLPs (Lu and Erdman, 2006). 
 
 
 
1.1.6.8.4 Polymerase chain reaction   
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Polymerase chain reaction (PCR) has grown in popularity as an alternative to immunotyping for 
identifying HADVs, offering a sensitive, rapid and readily accessible technology that can 
provide more definitive results (Chmielewicz et al., 2005 b).  PCR assays using species- and type 
– specific primers targeting the hexon, fiber, and VA (The viralassociated RNA is a type of non-
coding RNA found in Adenovirus RNA) coding regions have been described for some serotypes 
(Lu and Erdman, 2006).  However, because the HVRs (hyper variable regions) comprise a large 
discontinuous region of the hexon gene, multiple PCR amplication and sequencing reactions are 
required.  Moreover, HVR reference sequences have not been available for all HADV prototype 
strains, limiting the utility of this region for molecular typing (Lu and Erdma, 2006). 
Recent studies have suggested that shorter regions of the hexon gene correlate with serotype and 
therefore may be more practical for routine molecular typing (Lu and Erdman, 2006).   Sarantis 
et al. described a typing assay based on PCR and sequencing of HVR7 (Sarantis et al., 2004).  
Shimada et al. have proposed a similar assay that targeted a more conserved region of the hexon 
gene (Shimada et al., 2004). Quantitative PCR assays allow monitoring of the kinetics of the 
viral infection to distinguish between acute and persistent infections and estimation of the 
success of antiviral therapy (lion et al., 2003). 
 
 
1.1.6.9 Treatment 
Most infections are mild and require no therapy or only symptomatic treatment.  Since there is 
no virus-specific therapy, serious Adenovirus illness can be managed only by treating symptoms 
and complications of the infection. Deaths are exceedingly rare but have been reported (Wu and 
Martinez, 1990). 
 
 
1.1.6.10 Epidemiology of Adenovirus 
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Adenovirus infections occur worldwide in humans as well as in a variety of animals. With few 
exceptions, the human Adenovirus (HADV) serotypes are generally not pathogenic to animals, 
and animal Adenoviruses are only pathogenic within the species of origin (Taylor et al., 1977). 
Military recruits are highly susceptible to HADV associated ARD (Gray et al., 2000). In the 
absence of vaccine intervention,outbreaks are essentially continuous and result in large numbers 
of sick trainees, providing a unique setting to examine the molecular epidemiology and dynamics 
of transmission. Adenoviruses probably account for 3% of the infections in civilian populations 
(Cook et al., 1986).  Serologic surveys have furnished some estimates of the prevalence of 
Adenovirus infections in various populations.  Antibodies to HADV1, HADV2, and HADV5 are 
most common and are present in 40-60% of children (Brandt et al., 1969).  The incidence of 
antibodies to HADV3, HADV4, and HADV7 is low at the same ages (Brandt et al., 1969). These 
antibody results probably explain why adults are uncommonly infected with HADV1, HADV2, 
and HADV5 but are more susceptible to infections with HADV3, HADV4, and HADV7 (Cook 
et al., 1986).  During the surveillance for the virus watch studies, it was documented that only 
about 75% of the Adenovirus isolates were accompanied by an antibody response (Cook et al., 
1986). 
 
 
1.1.6.11 Transmission 
The transmission of Adenovirus infection and disease varies from sporadic to epidemic. The 
pattern often correlates well with the viral serotype and the age (children or adults) of the 
susceptible population (Knipe et al., 2001). Fecal-oral transmission accounts for most infections 
in young children. Initial spread may occur by the respiratory route, but the prolonged carriage in 
the intestine makes the feces a more common source during both the acute illness and 
intermittent recurrences of shedding (Cook et al., 1986).  The epidemiologic importance of the 
long latency in tonsil tissue is not known (Knipe et al., 2001). 
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1.1.6.12 The epidemic forms of Adenovirus 
The epidemic forms of Adenovirus disease were studied in different ways from that of the 
sporadic endemic occurrences (Knipe et al., 2001). The epidemics of acute respiratory disease 
(ARD) were well known during World War II, and this awareness preceded the isolation and the 
characterization of the first Adenovirus by about one decade (Knipe et al., 2001).  This ARD, 
which occurred almost exclusively in recently assembled military recruits, was most common in 
winter.  It did not occur in seasoned personnel in close contact with the recruits and was later 
identified as an HADV4 or HADV7 infection in most outbreaks (Fredman and Engler, 1993).  
This disease rarely occurred in similarly congregated college students, suggesting that additional 
factors, such as more crowded sleeping conditions or the fatigue associated with basic training, 
contributed.  In support of these cofactors has been the observation that ARD-causing 
Adenoviruses did not spread to civilian personnel in contact with the military (Knipe et al., 
2001).  In recruits congregated during the summer months, ARD often did not occur until the 
onset of colder weather in the fall.  Influenza A could be distinguished because it affected both 
experienced and new recruits.  Adenovirus-induced ARD often affected 80% of the recruits, with 
20% to 40% hospitalized.  The duration of infectivity was rather short; virus was not 
demonstrable after 4 days of illness (Knipe et al., 2001).  ARD outbreaks were effectively 
controlled by vaccination of recruits in the first few days of military service; however, recent 
interruption in the supplies of Adenovirus vaccine has resulted in the reappearance of the 
epidemic form of ARD (Gaydos and Gaydos et al., 1995; Gray et al., 2000; Kolavic-Gray et al., 
2002).  Infection resulting in several of the Adenovirus syndromes can be acquired in hospitals 
and can be spread as nosocomial infections.  Other adenovirus serotypes have probably been 
spread as nosocomial infections (Knipe et al., 2001). 
 
 
1.1.6.13 Endemic Adenovirus Infections of Young Children 
About 5% of ARD cases in children younger than 5 years of age are due to an adenovirus (Broor 
et al., 2007).  The usual symptoms include nasal congestion, coryza, and cough.  Other patients 
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may have an exudative tonsillitis that may be clinically indistinguishable from disease caused by 
the group A streptococcus (Harris et al., 1971).  The respiratory symptoms are often 
accompanied by systemic manifestations, such as generalized malaise, fever, chills, myalgia, and 
headache (Knipe et al., 2001).  The common serotypes are HADV1, HADV2, HADV5, and Ad6 
and occasionally HADV3, which are endemic in most populations (Knipe et al., 2001).  Sporadic 
cases may be indistinguishable from other viral respiratory infections, such as influenza, 
parainfluenza and respiratory syncytial virus (Bell et al., 1955).  If conjunctivitis accompanies 
the signs and symptoms already described, the disease is designated as pharyngoconjunctival 
fever (Bell et al., 1955).  The conjunctivitis is usually follicular, unilateral or bilateral, and 
characteristically mild.  In more severe cases, pneumonia may occur. Adenoviruses serotype 14 
is probably responsible for about 10% of the pneumonias of childhood (Louie et al., 2008).  Most 
patients recover from these lower respiratory infections, but some epidemics of HADV7 have 
resulted in considerable mortality (Gray, 2006).  Sequelae in those who recover may include 
bronchiectasis that can clinically manifest years after the primary infection.  
 
 
 
1.2 Goals of this study: 
 
1. To genotype the Adenovirus isolates from the 338 positive nasopharyngeal samples in babies' 
and children' aspirates collected at CBH between 2005 and 2010.  
2. To assess the association between Adenovirus infections and patient age, place of residence,as 
well as the infection season. 
3. To measure the clinical presentation of the patients when they were admitted to CBHwith 
Adenoviral disease cases (338 children). 
 
 
 
1.3 Description of Caritas Baby Hospital:  
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Caritas Baby Hospital (CBH) is one of the main pediatric hospitals in the south of Palestine.  It is 
located in Bethlehem and provides services mainly to patients from Bethlehem districts. Before 
Intifada started, babies from all over Palestine used to come for treatment at CBH. 
Caritas Hospital consists of two main departments the inpatient wards and the outpatient clinics. 
The inpatient has a capacity of 80 beds including incubators. The inpatient division is divided 
into three wards.  One ward is for premature babies and the other two wards are for babies and 
toddlers.  The wards offer general pediatric medical treatments excluding surgery and intensive 
care. It has the necessary diagnostic laboratories and adjoining facilities, as radiology and 
physiotherapy department.  The annual number of admissions range between 3000 to 3500.The 
outpatient clinic operates daily and evaluates on average 1600 patients annually. 
 
 
 
1.4 Ethical consideration  
This study was for scientific purposes only.  It does not discriminate against any particular 
religion, or ethnic group. All the study information has been taken confidentially; patient's names 
and their private information were anonymous. 
CBH ethical committee approved the participation in this research study (see 2.5; Appendix 1). 
 
 
 
1.5 Validity and reliability 
The laboratory of CBH is under direction of Dr. Musa Hindiyeh, a diagnostic clinical 
microbiologist, with double American board certification.  First board is in Medical Technology 
from the American Society of Clinical Pathology (ASCP) and the second board is in Diagnostic 
Microbiology and Public Health (DABMM) from the American Society of Microbiology.   
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Other issues taken into consideration to increase the validity and reliability of results:  
1. DFA (direct Immunofluorescence assay) results were read by technicians at CBH.  
2. All reagents were within the expiration date.  
3. Specimen transport media swabs were from COPAN, a well-known American company 
(www.copanusa.com) 
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2. Materials and methods   
 
2.1 Study design 
This study is case control study; cases were children diagnosed with Adenovirus (HADV) 
respiratory infection.  The study controls were children within the same age group diagnosed 
with respiratory tract infections caused by Influenza A (Flu A) or Parainfluenza (HPIV) viruses. 
 
 
 
2.2 Target population 
The target populations for this study were Palestinian children from southern Palestine, 
particularly Hebron and Bethlehem districts, who were between few days and seven years old.  
The setting was classified as city, village or camp. 
 
 
 
2.3 Sample setting 
This is a cross sectional reterospective study; a non random purposive sample was used to collect 
data about all children with respiratory tract infections who were admitted to Caritas Baby 
Hospital.  Further selection criteria for cases were: 
 
1- Children between few days and seven years old  
2- Children who were diagnosed with HADV respiratory tract infection. 
3- Children residing in southern Palestine. 
4- Children admitted to CBH with respiratory tract infection during all months of the year in 
the period between January 2005-December 2010  
5- Severity and symptoms of disease at the time of admission to CBH. 
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In case of the control group, the selection criteria were: 
1- Children between few days and seven years old  
2- Children who were diagnosed with Flu A or HPIV respiratory tract infections. 
3- Children residing in southern Palestine. 
4- Children admitted to CBH with respiratory tract infection during all months of the year in 
the period between January 2005-December 2010. 
 
 
 
2.4 The study setting 
The study setting was carried out in southern Palestine districts of Hebron and Bethlehem, the 
setting was classified into city, village or camp.  Figure 2.1 indicates the area, where the children 
reside.   
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Figure 2.1: Residency of children admitted to the CBH with respiratory tract 
infection caused by Adenovirus.  The figure was generated by the environmental 
research laboratory-AL-Quds University.  
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2.5 Ethical approval 
This study required both medical records of the children with Adenoviral infection as well as 
clinical samples on which the analysis were to be performed.  
for this regard, an application with three main requests was written and submitted to the ethical 
committee of the CBH.  The application was approved (Appendix 1). 
A. First request was directed to Dr. Musa Hindiyeh, director of CBH laboratory in order to 
obtain approval for checking the general lab records of children with confirmed 
respiratory tract infections.  After approval, out of a list with over 8000 records, children 
with diagnosed HADV, FLU A and HPIV infections were selected.  The general records 
regarding age, sex, Admission date and residency were collected. 
B. Second request was also directed to Dr. Musa Hindiyeh to obtain the Nasopharyngeal 
aspirates (NPAs) frozen samples of the children selected from the lab records with 
HADV respiratory tract infection. 
C. The third and final request was directed to the director of the CBH to obtain permission 
to look into the medical files.  This approval was necessary to obtain the clinical data, i.e. 
symptoms on admission and other clinical features of the children with HADV infection.  
 
 
 
2.6 Medical records 
2.6.1 General records 
The general records of the respiratory tract infection cases, which included age, sex, residency 
and admission date, were collected from the laboratory data of the CBH upon ethical approval A 
(see above).  These records were verified to decide which samples met the inclusion criteria for 
the study.  There were 343 cases of HADV infection, 466 of HPIV and 291 of Flu A between the 
Jan 2005 and Dec 2010.  Five of HADV cases, 15 of HPIV and 13 of Flu A were excluded due 
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to the residency in northern part of Palestine.  338 cases of HADV infection, 451 of HPIV and 
278 of Flu A were included in this study. 
2.6.2 Medical background records 
Upon ethical approval (see 2.5; Appendix 1), data from 150 files of Adenovirus infection cases 
were collected.  These data included the clinical picture of children on admission and intake of 
antibiotics.  The data were analyzed using SPSS to conclude the relevance between the clinical 
variables and the patients' cases. 
 
 
 
2.7 Data collection and initial analysis 
All data were collected in excel sheets, percentages and charts were created directly through 
these excel sheets.  For this data were arranged in an excel file, where each case, residency, age, 
sex, admission date (day, month and year) and type of infection (HADV, HPIV or Flu A) were 
included.  For Adenovirus infection cases, the clinical presentation infection and the resulting 
serotypes were added. 
 
 
 
2.8 SPSS data analysis 
All data included in this study were analyzed utilizing the SPSS program.  The SPSS analysis 
were performed based on the excel data sheet records from 2.7 (see above).   
 
 
2.9 Specimen collection 
Nasopharyngeal aspirates (NPAs) samples were collected from the respiratory tract of each 
patient at CBH according to rules and ethical consideration at CBH.  The collection of NPAs 
demanded a trained nurse and the technical procedure for collection was described in Abu Diabet 
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al (Abu Diab et al., 2008).  The DFA detection of Adenovirus in NPA specimen was also 
described in Abu Diab et al (Abu Diab et al., 2008).   For this, NPAs from each patient were sent 
to the CBH laboratory at room temperature within 30 min of specimen collection.  The NPAs 
were vortexed for 30 s and centrifuged at 300 x g for 10 min.  The cell pellets were washed three 
times with PBS washing buffer (phosphate buffer saline), and the cells were re-suspended in 0.5 
ml saline before a ~20µl cell suspension was spotted in the wells of an acetone-cleaned glass 
slide.  The slides were air dried before they were fixed in cold acetone for 10 min.  The cell 
concentrations were adjusted in NPA samples with large amount of secretions. A Light 
Diagnostics respiratory direct fluorescent antibody assay (DFA) viral screening and 
identification kit (Chemicon International; now part of Millipore) was used to stain for 
adenovirus, Influenza A and Parainfluenza viruses.  As recommended by the manufacturer.  
Fluorescein isothiocyanate-labeled antibodies against each virus were added to the appropriate 
wells; and the slides were incubated at 37°C for 30 min in a humid chamber.  The slide was then 
washed with 0.5% Tween in PBS for 45 s and then with distilled water for 15 s.  Finally the 
slides were air dried and the epithelial cells spotted on each slide were evaluated under a Hund H 
600 fluorescent microscope at x10 magnification.   Specimens were reported as inadequate if the 
number of epithelial cells was less than 20 cells per 10X field and no positive cells were spotted 
(Landry et al., 2000).   In order to evaluate the effectiveness of specimen collection, the epithelial 
cells were enumerated semi quantitative at 40X magnification according to the following criteria: 
+1, 1 to 10 cells; + 2, 10 to 20 cells; and +3, >20 cells.  All slides were screened for positive 
fluorescing cells at x10 magnification, and the results were confirmed at 40X magnification.  
Positive cells were also enumerated semi quantitative at 40X magnification according to the 
following criteria: +1, 0 to 1 cell; + 2, 1 to 10 cells; + 3, 10 to 20 cells; and + 4, >20 cells (Abu 
Diab et al., 2008).  
 
 
 
2.10 Extraction of HADV DNA from Nasopharyngeal aspirates samples  
 
Frozen NPAs at the CBH from 2005-2010 were transported on ice to the Virology laboratory; 
they were either frozen or subjected directly to DNA extraction. 
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For Adenoviral DNA extraction, Qiagen DNA extraction kit (Qiagen.cat no.51304) was used.  
The extraction steps were performed according to the manufacturer's instruction as follows: 
1. 20 µlQiagen Proteinase K were pipetted into the bottom of a 1.5 ml microcentrifuge tube.  
2. 200 µl samples were added to the microcentrifuge tube.  If the sample volume is less than 
200 µl, PBS was added to adjust the amount.   
3. 200 µl Buffer AL were added to the sample, mixed by pulse-vortexing for 15 s. 
4. Mixture was incubated at 56ºC for 10 min followed by a short spin down  
5. 200 µl ethanol (96-100 %) were added to the sample, mixed by vortexing and briefly 
centrifuged to remove drops from the inside of the tube lid.  
6. Mixture from step 5 was applied carefully to the QIAamp Mini spin column (in a 2ml 
collection tube) without wetting the rim.  The cap was closed and column in the 
collection tube was centrifuged at 8000 rpm for 1 min.  Place the QIAamp Mini spin 
column in a clean 2ml collection tube, and discard the tube containing the filtrate.   
7. 500 µl Buffer AW1 were added to the QIAamp Mini spin column and add without 
wetting the rim and centrifuged at 8000 rpm for 1 min.  Filtrate was discarded.  
8. The QIAamp Mini spin column was replaced in a clean 2 ml collection tube, 500 µl 
Buffer AW2 were added and.  Filtrate was discarded and centrifuging step was repeated.   
9. Finally, the QIAamp Mini spin column was placed in a clean microcentrifuge tube, 200 
µl elution buffers was added to the column and centrifuged at 14000 rpm for 3 min.  The 
filtrate in this step resembles the isolated DNA.  
 
 
 
 
 
 
 
 
2.11 Genetic detection of Adenoviral Hexon gene 
2.11.1 Design of PCR primers specific to adenovirusHexon gene: 
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Initially a primer pair to amplify a hexon gene fragment of 800bp was designed.  However, these 
primer pairs resulted in low frequency of amplification or no amplification at all due to the high 
genetic variety of the Hexon gene.  Therefore, well adjusted primer pairs in nested PCR mode 
were utilized (Lu and Erdman, 2006, table 2.1).  These Adhex primer pairs were designed to bind 
to all yet known 53 serotypes by inducing many variable bases to cover different point mutations 
leading to the different serotypes and Inosin (Lu and Erdman 2006, table 2.1).  Inosine is a 
purine (which occurs naturally in tRNAs) that can form base pairs with cytidine, thymidine, and 
adenosine.  Inosine is used in primers at positions where any of the four bases might be required 
due to sequence heterogeneity as is the case with HADV.  
 
 
 
Table 2.1: Primers used to amplify Hexon gene of Adenovirus. I= Inosin (A, T, C or G), X= (G, 
A, T or C), R= (A or G), Y= (C or T), according to IUPAC nucleotide code. 
 
 
 
2.11.2 Primer location  
To determine the site of the selected primer (see table 2.1), the hexon gene of different HADV 
genotypes were downloaded from the Pub med website http://www.ncbi.nlm.nih.gov/pubmed/  
to the Clone Manager Suite 7 program (scientific and educational software, www.scied.com).  
The primer sequences were searched using the search machinery of the program.  The 5' and 3' 
of each primer was determined on the gene.  The distance between the 5' of the external forward 
primer (AdhexF1) and the 5' of the external reverse primer (AdhexR1) resemble the size of the 
Primer (location on gene) Primer sequences  Source  
AdhexF1 (298-323) 5-txctttgacatxcgxggxgtxctxga-3 Erdman; 2006 
AdhexR1 (1157-1136) 5-ctgtcxacxgcctgrttccaca-3 Erdman; 2006 
AdhexF2 (328-350) 5-ggyccyagyttyaarccctaytc-3 Erdman; 2006 
AdhexR2 (1122-1097) 5-ggttctgtcxcccagagartcxagca-3 Erdman; 2006 
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PCR product to be expected after the nested PCR reaction with the two primer pair (the external 
and the internal primer pairs). 
 
 
2.11.3 PCR conditions 
A total PCR reaction of 25 µl included 8.5 µl extracted DNA (see 2.9), 1µl of each primer; 
AdhexF1, AdhexR1, AdhexF2 and AdhexR2 (each 10 pmol/µl) and 12.5 µl  PCR master mix 
(Ready Mix PCR Master Mix of Thermo scientific, Cat. No. AB-0575\Dc\LD).  The reaction 
was carried out in PCR tube (0.2 ml Axygen INC, USA) using Swift™ MaxPro Thermal Cyclers 
(ESCO Global, USA).  The PCR reaction started with a single hot start step for 5 min at 95ºC 
followed by 35 cycles in the following order, 1 min at 95ºC for denaturation, 1 min at 45 ºC for 
annealing and 2min at 72 ºC for extension respectively.  A following additional extension step 
was performed for a further 10 min at 72 ºC, assuring the complete extension of the amplified 
product.  The reaction was then cooled down to 4ºC and either frozen at -20ºC or directly 
separated as in 2.10.4. 
 
 
2.11.4 Detection of PCR product 
To detect the amplified gene product of the PCR reactions, agarose gel electrophoresis was used 
to separate the PCR product of expected 794 bp.  1 % agarose (Amresco) gel was prepared in 1x 
TAE (10 x TAE = 400nM Tris-HCL, pH 8.3; 200mM Na-Acetat; 20 mM EDTA).  The agarose 
was boiled until it was well dissolved, ethidium bromide or SYBER green (Invitrogen, cat 
number. S33102,  safe DNA gel stain) was added when agarose suspension cooled down to 
40ºC, carefully mixed, poured into agarose gel casting system (BioRad, UK  or Cleaver, U.S.A) 
and a desired comb was inserted.  8 µl of the PCR product was added directly into the gel well 
along with the DNA size control; 2 µl from 100 bp marker (gene ruler express DNA ladder, 
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(Fermentas, cat number. SM1558) added to detremine the correct band size.   Finally, the 
migrated bands in the agarose gel (100 mv for 30min using Bio Rad power supply) were 
visualized under UV light.  A digital image of the gel was taken using digital camera of the gel 
documentation system (Pharmacia Biotech). 
 
 
2.11.5 PCR Purification   
To purify the positive PCR product, a MinElute PCR purification Kit (Qiagen) was employed. 
This step is essential to get rid of PCR components and concentrate the desired PCR product for 
sequencing purposes or further analysis.  Purification kit (Cat. No. 28004) was used, as follows: 
1.  5 volume of Buffer PB was added to 1 volume of the PCR reaction mix.  In our case, 100 µl 
of buffer PB were added to 20 µl PCR reaction.  The color of the mixture is expected to turn 
yellow; otherwise Sodium acetate should be added. 
2.  To bind DNA, the sample mixture (from step 1.) was applied to the MinElute column and 
centrifuged at 17,900 g for 1 min.   
3.  The flow-through was discarded and 350 µl Buffer PE (wash buffer) was added to the 
MinElute column and centrifuged for 1 min at maximum speed (17,900 g).   
4. Flow-through was discarded and centrifugation step repeated.   
5.  For elution of the bound DNA, the MinElute column was placed in a clean 1.5 ml 
microcentrifuge tube.  10 µl Elution Buffer (10 mMTrisHCl, pH 8.5) or water was added to the 
center of the column's membrane.  After 1 min standing at RT, the column/microcentrifuge tube 
was centrifuged for 1 min at 17,900 g.  
6.  3 µl purified DNA was analyzed on a gel to verify the amount of eluted DNA.  The result was 
photographed using digital camera of the gel documentation system (Pharmacia Biotech).  This 
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photo reflects the DNA quality and quantity and was sent to the Bethlehem Heredity center along 
with the remaining 7 µl and the forward primer AdhexF2 for sequencing.  
 
 
2.12 Sequence analysis of hexon gene  
Sequencing was performed at the heredity lab of the Bethlehem University using sequencer 
machine ABI PRISM 3130 Genetic Analyzer.  The sequencing PCR reaction was performed 
with the reverse or forward primer in each reaction and BigDye® Terminator v1.1 Cycle 
Sequencing Kit(Applied Biosystems, USA, cat no. 4337451-100).   Once the sequence was 
ready, we received an email with the sequences attached. 
 
 
2.12.1 General overview of sequencing results 
The hexon gene sequences were readable using the Chromas lite program, Technelysium Ltd 
(www.technelysium.com.au/chromas.html).  Using the NCBI blast machine 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi), sequences were blasted for comparison with other 
known published adenoviral serotypes.  The adenoviral genotypes with the highest maximal 
identification with the Palestinian samples' sequences were documented for initial orientation of 
available Palestinian serotypes.  The accurate sequence analysis was performed using the 
DNASTAR program (see below). 
 
 
2.12.2 Reference sequences 
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In order to identify the adenoviral sequences revealed from Palestinian samples, published 
complete hexon gene serotypes were used as a reference.  Using the MegAlign program 
searching machinery (Lasergene version 8, DNASTAR Inc., Madison, WI, USA), complete 
hexon genes were downloaded and saved.  For precise and overall detailed alignment, serotypes 
of all subgenus (A-F) were downloaded beside the serotypes and subgenus found to be aligning 
with the Palestinian samples in the initial sequence analysis (see 2.12.1).  The published 
reference sequences were saved and referred to by the name of the serotypes and its accession 
number in brackets as published by the ncbi (www.ncbi.nlm.nih.gov).   The Palestinian samples' 
sequences hold the number given to the sample during this work and the year of sampling.  The 
samples of different years were given different colors to allow fast overview of the different 
years.    
 
 
2.12.3 Accurate sequence analysis of Palestinian human adenovirus  
2.12.3.1 Sequence alignment 
An accurate analysis of the Palestinian sequences was accomplished using the MegAlign 
program (Lasergene version 8, DNASTAR Inc., Madison, WI, USA).  All alignments were made 
using the Clustal W method and the following alignment conditions: 
Pairwise alignment was always slow accurate with gap penalty 10; gap length 0, 10 and DNA 
weight matrix IUB.  As for the multiple alignment gap penalty was also 10, gap length 0.20.  
These parameters were suggested by the program manager to fulfill the most ideal sequence 
alignment.  Hereby clustal W method aligns sequences using the method of Thompson et al. 
(1994).  Clustal W method was designed to create more accurate alignments than clustal V when 
alignments include highly diverged sequences.  Gap penalty is the amount deduced from the 
alignment score for each gap in the alignment. Gaps of the different sizes carry the same penalty, 
gap length penalty is the value deducted from the alignment score after first multiplying it by the 
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length of gaps. Longer gaps have a greater penalty than shorter gaps.  For example of alignment, 
please see figure 3.11.   
 
 
2.12.3.2 Building the phylogenetic tree 
Palestinian hexon gene and reference hexon gene sequences were downloadedinto the MegAlign 
program for DNA analysis (DNASTAR Inc., Madison, WI, USA).  An initial DNA based 
phylogenetic analysis was generated to gain an overview of all occurring Palestinian serotypes 
from all sequenced samples.  In this phylogenetic analysis case, the complete Palestinian 
sequences were aligned with the complete reference hexon genes of HADV-1, HADV-2, 
HADV-3 and HADV-5.  This phylogenetic analysis is not precise, but it gives a good orientation 
of the occurring Palestinian Adenovirus serotypes overall.   
 
The accurate phylogenetic analysis however, was based on the amino acid sequences of the 
variable region (HVR1-6) of the hexon protein (position 131 to 331 as defined by Crawford-
Miksza and Schnurr, 1996) and emphasized by Lu and Erdman (Lu and Erdman, 2006).  For this 
the reference HADV serotypes (2.12.2) were aligned from amino acid 131 to 331.  Each 
Palestinian sample's DNA sequence was first only aligned with its homology serotype DNA 
sequence (of the region amino acid 131-331).  The sequence of the Palestinian sample was 
compared with the reference homology serotype in the MegAlign and the Chromas program.  
This way, eye inspection was used to emphasize the nucleotide mismatches and gaps shown by 
the MegAlign and the sequence reading of the Chromas program.  The Palestinian sample 
sequence of the amino acid region 131-331 was saved for the yearly alignment.  Not all 
Palestinian sequences were used in this alignment, but the most convincing clear sequences were 
preferred to allow a precise genetic analysis.     
The most accurate Palestinian sequences (region 131-331) of each year were finally aligned with 
the amino acid sequences of the reference hexon genes (region 131-331) and subjected to 
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phylogenetic tree analysis.   The phylogenetic tree was generated by using the neighbor-joining 
method (MegAlign-DNASTAR program), built based on the percent identity and divergence of 
all sequences to each other as calculated by the MegAlign program.  The confirmation of this 
analysis was ensured by adding the bootstrapping value to the phylogenetic tree as calculated by 
the MegAlign program. 
 
The Bootstrap value is a popular way of evaluating the reliability of an inferred phylogenetic 
tree. The first step in a bootstrap analysis is to re-sample the alignment columns with 
replacement, i.e., in the re-sampled alignment, a given column in the original alignment may 
occur two or more times, while some columns may not be represented in the new alignment at 
all.  The re-sampled alignment represents an estimate of how a different set of sequences from 
the same genes and the same species may have evolved on the same tree.  For this a number of 
trials and a random seed number are essential.  Hereby the number of trials option indicates the 
number of times to compare the displayed tree with random tree constructs that use the neighbor-
joining methodology.  The random seed option makes bootstrapping consistent with the Clustal 
interface.  The number of trials used in this analysis was 1000, while the random seed was 111 as 
suggested to be the optimal range by the program maker of the MegAlign to fulfill the optimal 
analysis.  
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3. Results 
 
3.1 Respiratory tracts infections cases in caritas baby hospital: 
Between Jan 2005 and Dec 2010, over 8000 cases of children with respiratory tract infections 
were admitted to the Caritas baby hospital in Bethlehem.  14% of these cases were respiratory 
tract infections caused by Adenovirus (HADV), Influenza A (Flu A) and Parainfluenza (HPIV).  
There were 338 cases of HADV, 278 of Flu A and 451 of HPIV respectively.  The children were 
showing different disease severity of the upper respiratory tract infections, they were different in 
age, place of residency and other parameters.   
 
 
 
3.1.1 Residency of infected children  
Most children admitted to the CBH are generally from southern Palestine; Hebron and 
Bethlehem districts and so was the case for the children samples included in this study.    The 
few cases from Jerusalem and northern Palestine were excluded from the study.  Children were 
residing in the cities, villages or the camps in both districts.  Interestingly, the highest infection 
rate for either virus in our study sample was in children residing villages. 
68% of Adenovirus cases were from villages, while 21% were residing refugee camps and 11% 
came from cities. In case of Parainfluenza infection, 72% were from villages, 19% from refugee 
camps and 9% from cities.  Finally 75% of Influenza cases were from villages, 15% from 
refugee camps and 10% from cities (figure 3.1).   
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Figure 3.5 C:Parainfluenza infection per month from January 2005 to December 2010.  The 
actual number of cases each month and for each year was used for this analysis.   
 
  
 
Figure 3.5 D: Influenza A infection per month from January 2005 to December 2010.  The 
actual number of cases each month and for each year was used for this analysis.   
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3.1.6 Clinical features of Adenovirus infected children 
To check the severity of adenovirus infections, medications and other clinical features for the 
Adenoviral respiratory tract infections included in this study, a sub sample (150 cases) was 
chosen randomly from the total of 338 cases.  The medical files of these cases were studied and 
the results were summarized (see below). 
 
 
 
3.1.6.1 Clinical presentation (severity) 
The medical charts of the children showed clearly that Bronchitis, Bronchopneumonia (33.3%) 
and upper respiratory tract infections (URTI, 24.7%) were the main diagnosis of admission 
(figure 3.6).  In 2-5% of the cases, children suffered also from sepsis, Gastroenteritis, Otitis 
media, Meningitis, breathing difficulty, dehydration, Tonsillitis, congenital heart disease (CHD), 
conjunctivitis, chronic renal failure, yellow skin and febril convulsion (figure 3.6).  Single cases 
of the children suffered from croup, skin rash, hypoglycemia, anemia and cystic leukomalacia 
(referred to as others; figure 3.6).   
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3.2 Genetic analysis of the Adenoviruses circulating in southern Palestine 
3.2.1 Hexon gene PCR product 
All 338 NPA samples were subjected to DNA extraction followed by amplification reaction of 
the HADV Hexon gene.  The amplified PCR products were all around the expected Hexon gene 
fragment of 794 bp.  Interestingly, many samples' amplification products (PCR product) varied 
in size showing either smaller or bigger fragments around the 794 bp (Figure 3.8 A and B).  
These variations were detectable all over the years and had a maximum plus or minus of 50 bp as 
compared to the DNA marker.  On the other hand, a slight DNA smear was detected beside the 
clear PCR fragment.  This smear is known to PCR products amplified using insosine rich primer 
pairs as this was the case here. 
Figure 3.8 represents one of the amplification results of the year 2005.  This picture was 
consistent all over the years.  Most samples showed a very clear amplification band, while two 
samples (lane 10 and 11, figure 3.8 A) showed either very week amplification or no 
amplification at all.  This was explained by the fact that these samples were either week positive 
in the DFA or that the DNA extraction was not successful.  Interestingly, all samples' 
amplifications of the year 2010 were very successful, which is probably due to the fact that the 
samples were pretty fresh if compared with the samples of older years.   
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Figure 3.8.A: An example for HADV hexon gene amplification product from samples of the 
year 2005. Lane 1: marker; lane 2: 1-2005; lane 3: 2-2005; lane 4: 3-2005, lane 5: 4-2005; lane 
6: 5-2005; lane 7: 6-2005; lane 8: 7-2005; lane 9: 8-2005; lane 10: 9-2005; lane 11: 10-2005; 
lane 12: 11-2005; lane 13: 14-2005; lane 14: 13-2005; lane 15: 15-2005. Please see also 2.11.4.  
B: An example of HADV hexon gene product amplification elution from samples of the year 
2005.  Lane 1: marker; lane 2: 3-2005; lane 3: 5-2005; lane 4: 7-2005; lane 5: 13-2005; lane 6: 
14-2005.  For experiment details please see also 2.11.4 and 2.11.5.  
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3.2.2 Sequencing of the Adenoviral strains occurrence 
Thirteen percent (44 samples) of HADV cases from all years were subjected to the sequencing 
analysis.  Sequencing of 10% of samples for genetic analysis is scientifically very representative 
percentage to give an overall idea about genetic sequence of a species in a geographical area.  
The sequencing results showed clearly, that all the amplified fragments belonged to the Hexon 
gene of HADV as identified initially using the blast machinery of the NCBI 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi).  The 44 samples sequenced were chosen randomly 
taking the different sizes of PCR product (see 3.2.1) and its quality into consideration.  
 
 
 
3.2.3 Adenovirus serotypes in Palestine 
3.2.3.1 General sequence analysis  
Already the initial blast of the received sequences revealed that different HADV serotypes were 
represented in the Palestinian children.   However, some HADV serotypes were more dominant 
in the Palestinian children.  HADV serotype 2 (HADV-2); human adenovirus group C and 
HADV serotype 3 (HADV-3); human adenovirus group B were represented in 31.82% and 
45.45% of the samples respectively (figure 3.9).  Less dominant were another serotypes of the 
human adenovirus group C; HADV serotype 1 (HADV-1) and HADV serotype 5 (HADV-5), 
which were represented in 15.9% and 6.82% of the samples respectively (figure 3.9).  
Interestingly, in 5 Palestinian cases of HADV-1, the DNA sequences also aligned 80% with 
other human adenovirus group C types; HADV-6 and the very recently described HADV-57 
(Seto et al., 2010).  
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3.2.3.2 DNA based phylogenetic analysis of southern Palestinian HADV 
isolates  
The Hexon gene sequences of the different Palestinian HADV isolates were subjected to genetic 
alignment using the MegAlign program (DNASTAR Inc., Madison, WI, USA).  In this case, all 
sequenced Palestinian samples were first subjected to alignment with reference hexon genes of 
serotypes 1, 2, 3, 5 (figure 3.10).  These reference hexon genes were specifically chosen based 
on the initial alignment results using the blast machinery of the NCBI (see 3.12.3.1).  The 
alignment was performed using the Clustal W method and the alignment parameters mentioned 
in 2.12.3.1.  The result shown in figure 3.10 is a general alignment showing the rough homology 
of the Palestinian samples' sequences to HADV-1, 2, 3, 5 using the comlete DNA sequences of 
Palestinian samples and reference hexon gene sequences.  This knowledge was used to establish 
the accurate phylogenetic analysis (see below).  As indicated in table 3.4 and clearly shown in 
figure 3.10, samples from all the years showed homology to HADV-2.  Homology to HADV-3 
in the Palestinian samples was also seen all over the years with exception to 2009.  In case of 
HADV-1, homology was presented all over the years, with exception of the year 2008.  On the 
other hand, only samples from the year 2005 and 2006 showed homology to HADV-5.  Due to 
the high number of samples subjected to this analysis, different colors were used to refer to the 
different years, in attempt to make viewing this figure (figure 3.10) easier and more accessible.  
The rooted phylogenetic tree shows 2 main branches; A and B.  The Adenovirus subgenus C is 
branched together on branch A, while Adenovirus subgenus B is branched on the main branch B 
and accordingly the Palestinian samples resembling each subgenus.   On branch A1, sample 28 
(2006) showed the highest homology (99%) to HADV-2, being branched on the same node.  
Samples 40 and 11 (2008), sample 66 (2007), sample 1 (2010), sample 58 (2009) and 67 (2007) 
showed 95-97% homology to HADV-2 and therefore were branched next to the HADV-2 node.  
Samples 7 and 13 from the year 2005, samples 73, 80 and 83 (2009), sample 26 (2006) and 
sample 51 (2008), all were sub-branched further below with 90-95% homology to HADV-2.   
 
On branch A2, sample 4 (2005) showed the highest homology (99%) to HADV-5, being 
branched with at the same node.  Samples 3 (year 2005) and 24 (2006) showed 97% homology to 
HADV-5 and were therefore branched next to the HADV-5 node.   
51 
 
 
On branch A3, sample 60 (2007) showed the highest homology (99%) to HADV-1, while 
samples 3 (2010) and 75 (2007) were also highly homolog (97%) to HADV-2.  Samples 6 
(2005), 85 (2009), 71 (2009) and 31 (2006) were only 93-95% homolog to HADV-2 and 
therefore branched further away from HADV-2 node. 
 
On main branch B, samples 12 (year 2010), 14 (year 2008), 11 (2010), 8 and 8b (2005), 10 
(2010), 7 (2010) and 16 (2008) showed the highest homology (97%) to HADV-3. Samples 23 
(2005) and 23 (2006), 29 (2006), 12 (2005), 13 (2007), 9 (2010) showed 95% homology to 
HADV-3.  Samples 14 and 15, 9, 5, 24 and 2 (2005) were less homolog (90-94%) to HADV-3 
and therefore branched further below on a different node.  
 
8 and 8b (2005) are actually the same sample being subjected to a second sequencing analysis to 
obtain better sequencing results. 
. 
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Figure 3.10 
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Figure 3.10:  DNA alignment of the southern Palestinian HADV samples compared with 
reference serotypes HADV-1, HADV-2, HADV-3 and HADV-5 (ncbi accession numbers in 
brackets).  The phylogenetic tree was generated by using the neighbor-joining method 
(MegAlign-DNASTAR program).  The length of each pair of branches represents the distance 
between sequence pairs, while the units at the bottom of the tree indicate the number of 
substitution events.  Nucleotide substitution per 100 residues reflects one of the bases for the 
sequence alignment in this figure only. 
 
 
 
3.2.3.3 Amino acid molecular typing of Palestinian HADV isolates  
As sequences were subjected to nucleotide blast machinery (see above), some sequences showed 
homology not only to one HADV known serotype, but also to another one or two HADV 
serotypes.  On the other hand, no Palestinian sequence showed a 100% homology to any of the 
published HADV serotypes.  To further investigate this finding, the Palestinian sequences were 
subjected to amino acid homology analysis as introduced by Crawford-Miksza and Schnurr 
(Crawford-Miksza and Schnurr, 1996).  Hereby, the amino acid sequences of the high variable 
regions 1-6 (HVR1-6, amino acid position 131 to 331) were subjected to alignment and analysis.  
Since the genetic differences in the hexon gene are responsible for the different serotypes, the 
amino acid sequences of the high variable region of the hexon gene reflect the accurate analysis 
of different human adenovirus genotypes.   
 
The alignment was performed as detailed in 2.12.3.1.  Due to the high amount of data in one 
figure, each year was aligned separately with the reference HADV serotypes.  Figure 3.11 shows 
an example of amino acid alignment for the samples of 2010.  As the case for most species, some 
sequences were highly conserved (in black), other were not conserved (in red).  The blue refers 
to those amino acids, which are indeed different but not on functional basis.  All amino acid 
alignments were performed using the MegAlign DNASTAR program's Clustal W method.  
Alignment conditions are detailed in 2.12.3.1 and 2.12.3.2. 
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Phylogenetic analysis of 2005 HADV samples in figure 3.12 showed that they aligned with 
HADV-1 represented by sample 6-2005, HADV-2 represented by 7-2005, HADV-5 represented 
by 3-2005 and 4-2005 and HADV-3 represented by 8-2005 and 15-2005.  Sample 8-2005 
showed high homology to HADV-7, a fact which was not detected using the DNA alignment or 
the direct blast method.  The alignment and so homology between HADV-1 and sample 6-2005, 
between HADV-2 and 7-2005 was very high strengthened by a perfect bootstrap value of 100. 
 
6-2005 aligned with a lower bootstrap value with HADV-6 (bootstrap value=64.6) and HADV-
57 (bootstrap value =74.3).   Although 4-2005 showed higher homology with HADV-5 
compared to sample 3-2005, its bootstrap value is 65.6 compared to 85.4 bootstrap values for 3-
2005.  Both, 8-2005 and 15-2005 aligned with HADV-3.  8-2005 showed also homology to 
HADV-7. 
 
 
Year 2006 
Phylogenetic analysis of 2006 samples showed that they align with HADV-3 represented by 29-
2006, HADV-5 represented by 24-2006, HADV-2 represented by 28-2006 and HADV-1 
represented by 31-2006.  The high bootstrap values on nodes for these samples' alignment 
confirm the homology.  Interestingly, sample 29-2006 shows a further homology to HADV-7, a 
fact which was not detectable using the initial blast method used above.   
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3.3 Annual Distribution of human adenovirus serotypes 
The different serotypes of HADV were not present all over the years equally. While HADV-2 
serotype was present all over the years 2005-2010, HADV-1 was present in all years except 
2008, HADV-3 was present in all years except 2009 and HADV-5 was present only in 2005 and 
2006 (table 3.4). 
 
 
SEROTYPES 2005 2006 2007 2008 2009 2010 
HADV1 + + + _ + + 
HADV2 + + + + + + 
HADV3 + + + + _ + 
HADV5 + + _ _ _ _ 
 
Table 3.4: The Adenovirus serotypes circulating in southern Palestine.  Sequences resulted from 
each year's samples were subjected to sequence blast analyses using the NCBI machinery (see 
above).  The different serotypes in each year were documented.  
 
 
 
 
 
 
 
 
 
 
 
 
3.4 Seasonal variation of Adenovirus serotypes 
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Dheisha, serotypes HADV-1, HADV-2 and HADV-3 were present.  HADV-1, HADV-2, 
HADV-3 and HADV-5 were found all over the villages in Bethlehem and Hebron districts.   
Also in regards to age group and sex of the children, no further specific distribution of serotypes 
was found.  
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4. Discussion  
 
Adenovirus is a significant causative agent of respiratory tract disease in pediatric and adult 
patients.  Numerous outbreaks of acute respiratory infections caused by HADV have been 
reported during the last decade in many countries (Harley et al., 2001; Ryan et al., 2002; 
Palomino et al., 2004; Chmielewicz et al., 2005a; Zhang et al., 2006; Mizuta et al., 2006; Chang 
et al., 2008; Zhu et al., 2009; Esposito et al., 2010; Kandel et al., 2010; lee et al., 2010; Rebelo-
de-Andrade et al., 2010).  Some outbreaks resulted in high morbidity and fatal death in neonatal 
and pediatric units, in children admitted to hospitals (Wu et al., 1990; Pinto et al., 1992; Mitchell 
et al., 2000; Carballal et al., 2002; Louie et al., 2008; Rebelo-de-Andrade et al., 2010), in schools 
(Zhu et al., 2009) and most strikingly in military camps (van der Veen et al., 1969, Mantyjarvi, 
1966; Chmielewicz et al., 2005a) and military hospitals (Lessa et al., 2007).   
 
Presented here are genetic epidemiological data analysis of 338 records of Adenoviruses isolated 
from childrenresiding southern Palestine between 2005 and 2010.  First, epidemiological 
analysis of Adenovirus was compared with respiratory tract infections Parainfluenza and 
Influenza A residing the same geographical area.  Second, the genetic analysis results of the 
variable Palestinian Adenovirus serotypes were analyzed accordingly with the epidemiological 
factors and patients records. 
 
 
 
4.1 Residency of infected children 
The highest percentage of infections among children in our sample population with Adenovirus, 
Parainfluenza and Influenza was located in villages with 68%, 72% and 75% respectively.  This 
can be due to the high possibility of contact between children in the village community.  
Generally, high contact between children is granted by the fact that in most villages, only one or 
two kindergartens and schools are available.  On the other hand, most households are crowded, 
since the families are bigger than in cities.  All these factors raise the possibility for high contact 
between children overall (Munoz et al., 1998, Lessa et al., 2007).  On the other hand, 
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socioeconomic status of these children residing villages play a crucial role in respiratory tract 
infections. Adults and children of lower socioeconomic status are known to be at higher risk for 
a wide range of communicable infectious diseases, especially respiratory infections (Cohen, 
1999).  In the city, the percentage of occurrence was 21% for Adenovirus, 19 % for 
Parainfluenza and 15 % for influenza respectively.  This may be due to the numerous available 
Kindergartens and schools, plus smaller household family members compared to villages, which 
are essential factors for decreased respiratory tract infections.                    
Surprisingly, the number of cases from refugee camps was the lowest in this study, which can 
only be explained by the fact that camps' residents rather take advantages of clinical services 
provided by the UN.  This means that the total number of children admitted to the CBH from 
refugee camp may be small, compared to the number referring to the UN health centers.    
The SPSS analysis showed that there is no significant association between Adenovirus infection 
and district residency as (P value > 0.05[95%CI= 1.7113-1.6558]).  In regard to Parainfluenza, 
there was a difference in distribution of infection according to residency (mean 
difference=1.57103 [95% CI= 1.6005-1.5415]) and similarly for Influenza (mean 
difference=1.450 [95 %CI= 1.49-1.410]). 
 
 
 
4.2 Age distribution of infected children 
The most striking finding was the very small numbers of infection cases involving school age 
children (age 5 years-11 years).  This may suggest that they have already been exposed to the 
common endemic serotypes of Adenovirus early in life and have thereby established a protective 
immunity (Cooper et al., 2000).  Children younger than 2 years were the most susceptible to 
respiratory tract infections of Adenovirus with 62% for age group 0-1 and 27% for age group 
1.1-2 compared with 11% only in school age children respectively.  Adenovirus outbreaks were 
more likely to occur in young children and infants (Wu et al., 1990; Pinto et al., 1992; Mitchell et 
al., 2000; Carballal et al., 2002; Louie et al., 2008; Rebelo-de-Andrade et al., 2010).   
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Parainfluenza infections are most severe in infants and become less severe with age.  By school 
age, most children have been exposed to Parainfluenza virus so most adults have antibodies 
against Parainfluenza (Karron and Collins, 2007).  Similarly, age group 0-1 showed the highest 
percentage of Parainfluenza infection cases (73.7%).  The same was noticed in influenza A 
infection, the risk of complications is higher in young infants than it is for any other age group 
(Brankston et al., 2007).  In this study, Influenza infection cases among infants were (66%).  
These findings were confirmed statistically, as the correlation between age and the severity of 
Adenovirus infection was clearly present (r=0.110), but even more significant for Parainfluenza 
infection (r=0.127).  The lowest significant correlation was in case of Influenza infection 
showing a low value of Pearson correlation (r=0.018). 
 
 
 
4.3 Sex of infected children 
This study showed clearly that in our sample males were more likely to be infected with 
respiratory tract infections Adenovirus, Parainfluenza and Influenza.  Male and female ratio was 
calculated according to the frequency of either case all over the six years period (2005-2010) 
relatively to the total number of cases.  The percentage for the three types of infections were very 
similar; 62% males in case of Adenovirus infection, 64% in case of Parainfluenza and 64% in 
case of Influenza respectively.  This sex based infection incidences were statistically significant 
for Adenovirus (mean difference=1.683[95% CI= 1.6005-1.5415]), for Parainfluenza (mean 
difference=1.57103 [95%CI =1.6005-1.5415]) as well as for Influenza (mean difference= 
1.33012   [95%CI= 1.3959-1.3384]) respectively.  This finding was previously confirmed for 
Adenovirus respiratory tract infections (Cooper et al., 2000; Schmitz et al., 1983), however, this 
phenomenon may vary for specific Adenovirus serotypes (Cooper et al., 2000; see also 4.7) 
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4.4 Seasonal occurrence of infections 
Results for seasonal occurrence of Adenovirus demonstrated that the infection occurred 
throughout the whole year, but generally it was more significant in the months March to May.  
The SPSS analysis showed an agreement with these results, as there was a correlation between 
Adenovirus infections and season of occurrence (P value<0.001).  Although there was no clear 
evidence for seasonal correlation of Adenovirus infection generally, some Adenovirus serotypes 
correlated specifically to one or two months throughout the year and were also found in some 
years, but not in others (Cooper et al., 2000; see also section 4.7)  
The case was generally different for Influenza A and Parainfluenza, since both occurred 
seasonally rather than uniformly throughout the year especially for Influenza A (3.5 C and D).  
These results are consistent with previous studies demonstrated by Chew et al. (Chew et al., 
1998).  One possible explanation for this is that people are indoors more often during the winter, 
they are in close contact more often, and this promotes transmission from person to person 
(Karron and Collins, 2007). Therefore, the SPSS analysis showed a clear mean difference of 
occurrence between Parainfluenza and season (95%CI=1.5415-1.6005), as well as Influenza A 
and season (95%CI =1.7156-1.7678). 
 
 
 
4.5 Severity of infection, Fever and cough in Adenovirus infected children 
The major Adenovirus associated diseases as indicated in medical charts were bronchiolitis and 
bronchopneumonia (33.3%), upper respiratory tract infection (24.7%) and sepsis (5.3%).  Indeed, 
the most common recognizable clinical presentations of Adenovirus infection are pneumonia, 
bronchitis/bronchiolitis, conjunctivitis, pharyngoconjunctival fever, and upper respiratory tract 
infections or common cold symptoms (Wu et al., 1990; Ruuskanen et al., 1992; Singh-Naz et al., 
1993; Hemming, 1994; Denny, 1995; Munoz et al., 1998; Palomino et al., 2000; Palomino et al., 
2004; Chmielewicz et al., 2005a; Yeung et al., 2009).  Interestingly, these symptoms remain 
similar in different age groups (Cooper et al., 2000).  
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According to the medical charts, 80% of children admitted to the CBH with Adenovirus 
infection suffered from fever as a major symptom of lower respiratory disease whereas, 50% 
only suffered from cough.  There was a significant association between fever and Adenovirus 
infection (P value<0.001 [95%CI= 1.7113-1.6558]) as well as between cough and Adenovirus 
infection (P value <0.001 [95%CI 1.7113-1.6558]).  Cough and fever are common symptoms 
related to different respiratory tract infections (Chmielewicz et al., 2005a); nevertheless they 
belong to known clinical features in Adenoviral respiratory tract infections with (Munoz et al., 
1998; cooper et al., 2000; Hsieh et al., 2009).  
 
 
 
4.6 Medication and treatment of Adenovirus infected children 
Viral infections cannot be treated with antibiotics and so Adenovirus infections, however, 
alternative antibiotic like Clindamiycin and Tetracyclines are sometimes prescribed along with 
ibuprofen by physicians in extreme cases to help with fever, pain and inflammation.  There are 
very few options of antiviral medications for use in case of Adenovirus infections.  Though, 
certain serotypes of Adenovirus may respond to Ribavirin antiviral therapy in vitro, but most 
serotypes respond to Cidovir (Morfin et al., 2005; 2009).   
In this study, antiviral therapy was not administered in any of the children with adenoviral 
respiratory tract infection; however, most of these children (70%) have taken Antibiotics as 
clearly stated in the medical files.  In most cases, antibiotics were administered automatically, 
before the CBH laboratory diagnostic result was reported or even before the children were 
admitted to the CBH for health care.  Antibiotics may be useful in some cases to prevent further 
complications caused by bacterial infections due to weak immunity during viral infections or in 
case of viral co-infection with bacterial agent (Franz et al., 2010; Shiley et al., 2010).  On the 
other hand, general prescription of antibiotics before diagnosis or because exact diagnosis is not 
possible is a common mistake made by most physicians which have led worldwide to more and 
more resistant bacterial strains and unexpected complications in patients (Rocholl et al., 2004; 
Lautenbach et al., 2010; Shiley et al., 2010; Pavia, 2011). 
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4.7 Adenovirus serotypes in Palestine 
This study demonstrated that HADV-1, HADV-2, HADV-3 and HADV-5 were the most 
common serotypes circulating in southern Palestine.  The different serotypes were not equally 
distributed all over the years or all over the months.   
Similar genetic epidemiology studies had shown that Adenovirus serotypes HADV-1, 2, 3, 5, 6, 
and 7 were mainly involved in respiratory tract infections in children in Argentina, Iceland, 
Chile, Taiwan, Canada, China, Malaysia, Korea, Israel and the USA (Kajon and Wadell, 1992; 
Johansson et al., 1993; Palomino et al., 2004; Hsieh et al., 2009; Yeung et al., 2009; Zhu et al., 
2009; Abd-Jamil et al., 2010; Lee et al., 2010; Mandelboim et al., 2011; Selvaraju et al., 2011).  
Adenovirus serotypes 1, 2 and 3 were detected in most of these studies, serotype 5, however was 
detected in Iceland and Taiwan (Johansson et al., 1993; Hsieh et al., 2009).  Adenovirus 
serotypes; HADV-1, 2, 3, 5, 6 and 7 were associated with respiratory disease (p<0.001), most 
consistently with mild upper respiratory tract disease (Louie et al., 2008).  These same serotypes 
are known to be associated with almost 85% of the HADV infections in infants and children 
(PA, P, 1962).  
Although most studies on Adenoviral infections were unable to show a clear evidence for 
seasonal correlation, specific serotypes correlated to specific seasons (Chew et al., 1998; Cooper 
et al., 2000; see also 3.3 and 3.4).  Also here, HADV-2 and HADV-3 seems to be more frequent 
in spring and winter seasons.   
Of all Adenovirus serotypes detected in southern Palestine, only HADV-3 (subgenus B) was 
shown in numerous studies to be responsible for outbreaks; in the USA, Taiwan, Korea and 
Portugal (Ryan et al., 2002; Chang et al., 2008; Lee et al., 2010; Rebelo-de-Andrade, 2010).  
Fatal Adenovirus serotype 14 (Louie et al., 2008; Lessa et al., 2007) was not detected in any of 
the Palestinian samples.  Although there was no record of possible outbreak in southern 
Palestine, the serotyping results show clearly that HADV-3 was the most common serotype in 
the year 2005, since it was detected in 9 samples out of 14.  In the year 2010, HADV-3 was 
detected in 5 samples out of 7.  These data may provide evidence for a possible unknown 
outbreak, since HADV-3 was also reported to be detected in both, outbreaks and sporadic cases 
(Lee et al., 2010).  Some Palestinian samples, which showed high homology to HADV-3, were 
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also homolog to HADV-7 (see 3.2.3.4).  HADV-7 belongs also to subgenus B and was also 
shown in numerous publications to be responsible for several outbreaks (Kajon et al., 1990; 
Larranaga et al., 2000; Mitchell et al., 2000; Carballal et al., 2002; Erdman et al., 2002; Ryan et 
al., 2002; Gray et al., 2005; Rebelo-de-Andrade et al., 2010). 
 
 
 
4.8 Phylogenetic tree analysis of Palestinian Adenoviruses 
The reference sequences used for phylogenetic analysis represent all known Adenovirus 
subgenus (A-F).  HADV 31 represents subgenus A, HADV-3 and HADV-7 represent subgenus 
B, HADV-1, 2, 5, 6 and 57 represent subgenus B, HADV-8, 9 and 27 represent subgenus D, 
HADV-4 represents subgenus E and finally HADV-40 represents subgenus F.   
 Initially the phylogenetic analysis was performed using the DNA sequences of all samples.  This 
was a general overview of the Palestinian samples, showing their general relevance to reference 
HADV serotypes.  Some previous studies on Adenovirus based the serotyping on Restriction 
enzyme analysis (Adrian et al., 1986; Niel et al., 1991; Kajon et al., 1996), however more recent 
studies made use of DNA sequences by simplex or multiplex PCR assays for specific serotypes 
(Lu and Erdman, 2006; Adhikary et al., 2004; Lee et al., 2010).  The second way of genotyping 
was based on using primers which specifically amplify one or few serotypes and confirmed per 
sequencing analysis.  
However, precise analysis of the Adenovirus genotypes requires the involvement of amino acid 
sequences of the hexon gene variable region (HVR1-6), better HVR1-6 and HVR-7 (Xu and 
Erdman, 2001, Zhu et al., 2009; Biere and Schweiger, 2010).  This is logic and more convenient, 
since antigenic characteristic of the HVR resembles the baseline of the necessity of serotyping 
procedure.  Any amino acid substitution event will result in a different antigenic characteristic 
and probably a new serotype, if the amino acid substituted was critical for the antigenic protein 
conformation.  Applying the amino acid alignment on the Palestinian sequences granted a new 
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insight into these sequences, their relevance to published reference serotypes and the impact of 
such data on the long term.   
The DNA blast and later the DNA sequence alignment and phylogenetic analysis had shown that 
many of the Palestinian serotypes, which showed homolog to HADV-1, were also homology to 
HADV-6 and HADV-57 (all subgenus C).  On the other hand, the Amino acid sequence 
alignment and phylogenetic analysis revealed that most of the Palestinian samples related to 
HADV-3, were also related to HADV-7.  One possible explanation will be that such samples 
may be a mix of the 3 viruses (HADV-1, HADV-6 and HADV-57) represented mainly by 4 
samples (6-2005,   60-2007, 85-2009 and 3-2010) or of the two viruses (HADV-3 ad HADV-7) 
represented mainly by 8 samples (8-2005, 29-2006, 13-2007, 14-2008, 16-2008, 10-2010,       
11-2010 and 12-2010).  Indeed, there are many evidences of frequent recombination between 
Adenoviruses resulting in new serotypes (Lukashev et al., 2008; Seto et al., 2010; Biere and 
Schweiger, 2010).  This fact explains also why so many new serotypes are joining the long list of 
Adenovirus known serotypes every year.  Within a year and a half, needed to accomplish this 
work, the number of Adenovirus serotypes raised from 51 up to 58 (Lu and Erdman, 2006; Jones 
et al., 2007; Walsh et al., 2009; Seto et al., 2010; Ishiko and Aoki, 2009; Walsh et al., 2010; 
Robinson et al., 2011; Liu et al., 2011).  It is also noteworthy to mention that many Palestinian 
serotypes showing high homology to HADV-2, also showed homology to HADV-1, HADV-6 
and HADV-57, all subgenus C represented mainly by 9 samples (7-2005, 28-2006, 66-2007,   
67-2007, 11-2008, 40-2008, 58-2009, 80-2009 and 1-2010). 
Palestinian sequences, which were not distributed on the phylogenetic tree directly at the same 
final node, where either of the reference published serotypes is distributed, provide evidence for 
a new recombination of a serotype.  This was the case for at least 6 samples; 3-2005, 8-2005,   
15-2005, 31-2006, 67-2007 and 11-2008.  This assumption will be subjected to further 
computational and genetic analysis, but is strongly supported by the bootstrapping values 
calculated by the MegAlign program.   
Bootstrap values above 95 at the final node, where the reference serotype and Palestinian 
serotype is distributed (i.e. samples 6-2005 and 7-2007) refer a very high homology and 
therefore for the exact concurrent serotype.  This means that 6-2005 is 100% HADV-1, while 7-
2005 is 100% HADV-2.  All cases, where bootstrap values were below 90 refer to high 
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heterology in the DNA or the amino acid sequencing and so for a yet unknown serotype, which 
could not be tightly correlated to one of the existing reference serotypes, which represent all the 
Adenovirus subgenus.  
 
 
4.9 Recommendations 
Rapid diagnostic approaches of respiratory tract infections can be very critical in patient’s life 
especially in outbreaks occasions.  Zhu et al (2009) had reported the identification of HADV-11, 
which was never been correlated earlier with outbreaks or fatal infections, to be responsible for 
an outbreak in china, which led to death in a school outbreak.  This study and discussions of 
scientific reports presented here emphasize the necessity of developing rapid and accurate 
diagnostic methods, which enable the identification of the specific bacterial and viral agents 
causing respiratory tract infections within one day or less.  A precise diagnostic should play a 
major role whether to consider administration of antibiotics, anti viral or no drugs at all.   
Generally, most physicians and pediatricians in Palestine hurry up in conclusions and prescribe 
basically antibiotics for all symptoms correlating to a possible respiratory tract infection.  Studies 
presented here demonstrate that prescription of antibiotics without having the precise diagnosis 
of an infection may turn out to be negative, rather than a positive effect on a patient.  Treatment 
with antibiotics must be subjected to more tight rules.  On the other hand, the economical impact 
of such unnecessary costs can be prevented and rather invested somewhere else in the health 
section.   
Study data presented here show that antibiotics problem do not seem to be a Palestinian problem 
only, not even a third world problem.  Most industrial countries suffer from over usage of 
antibiotics, but compared to Palestine and most countries in the third world, rules do not make 
access to antibiotics from each pharmacy around the corner possible.  On the other hand, 
research and studies in this area had been flourishing in the industrial world, spreading an 
enormous awareness in those societies among even simple people.  All these actions are urgently 
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needed in Palestine, taking into consideration the extremely cheap prices for antibiotics produced 
by local companies. 
Altogether, we strongly recommend to control access to antibiotics and to receive high priorities 
from responsible authorities to support molecular epidemiology studies to be used on daily basis 
and not for research only.  Molecular epidemiology data are only then useful, when they can be 
applied in daily life for the benefit of human being.           
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Appendix 
Southern palestine regions which were included in this study: 
A` roub c   
A` sakreh 
A`yda camp 
Abu Njeim 
Abu njem 
Abu Suhweile 
AdhDhahiriye 
Aida c  
Al  Masara 
Al Askar 
Al Doha 
Al Miniya 
Al Rashaideh 
Al Shawawre 
Al Walajeh 
Alkhader 
AnNajade 
ArRihiye 
Arab arrashayde 
Ash shuyukh 
Azzeh c  
BaniNa`im 
Battir 
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Behtlehem 
BeitFajjar 
Beit Anan 
BeitAwwa 
Beitkahil 
BeitUla 
BeitUmmar 
Bietsahour 
BietTa`mirash 
Deheisheh c 
DeirSamet 
Doura 
E`beidiyeh 
El Doha 
Fawwar c  
Halhoul 
Harmalah 
Hebron 
Husan 
Idna 
Jaba` 
Joretelsham 
Kharas 
KhashemAl  Karem 
Kisan 
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MarahIma`ll 
MarahRabal 
Nahhalin 
Nouba 
Ort Alshama` 
Rakhma 
Sa`ir 
Samou 
Samu 
Sheokh 
Sourif 
Ta`amreh 
Taffoh 
Taffuh 
Tarqumya 
Thahriyeh 
Tqou 
Umm lasfa 
Umm Salamona 
Urtas 
Urtas 
Wad El Nees 
Wad Foukin 
Wad Rahhal 
Yatta 
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Za`tara 
 
